GI
DGX icon

GLG Inc’s Quest Diagnostics DGX Stock Holding History

GLG Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$819K Hold
15,295
– – 0.02% 538
2013
Q3 		$945K Hold
15,295
– – 0.02% 565
2013
Q2 		$927K Buy
+15,295
New +$911K 0.02% 465

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GLG Inc's DGX Position: Q4 2013 in Review

GLG Inc held its Quest Diagnostics (DGX) position steady in Q4 2013 at 15,295 shares worth $819K. The position accounts for 0.02% of the portfolio, ranked #538.

GLG Inc first reported a position in DGX in Q2 2013 and has held it in 3 quarters since. The position peaked at $945K in Q3 2013. 455 funds tracked by Wall St. Rank hold DGX as of Q4 2013.

  • GLG Inc held 15,295 shares of Quest Diagnostics worth $819K as of Q4 2013.
  • GLG Inc left its Quest Diagnostics share count unchanged in Q4 2013.
  • Quest Diagnostics made up 0.02% of GLG Inc's portfolio in Q4 2013, its #538 holding.
  • GLG Inc first reported a position in Quest Diagnostics in Q2 2013 and has held it in 3 quarters since.
  • GLG Inc's Quest Diagnostics position peaked at $945K in Q3 2013.
  • 455 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.